TP53 and glioblastoma: Results from The Cancer Genome Atlas (TCGA) program revealed that the most frequent alterations in GBM predominantly affect three cell-signaling pathways: the p53 pathway, the retinoblastoma (Rb) pathway, and the receptor tyrosine kinase (RTK) signaling pathways [13].